Dawang, Ginalyn S.
HRN: 04-48-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2023
CEFUROXIME 1.5GM (VIAL)
02/28/2023
03/01/2023
IV
1.5
Q8
LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes